单克隆抗体
医学
抗体
癌症
免疫疗法
生物标志物
靶向治疗
生物标志物发现
癌症研究
免疫学
蛋白质组学
内科学
生物
生物化学
基因
作者
Saikat Ghosh,Pie Huda,Nicholas L. Fletcher,Douglas Houghton Campbell,Kristofer J. Thurecht,Bradley J. Walsh
标识
DOI：10.1080/14712598.2022.2033204
摘要
Clinical development of novel anti-GPC-1 antibody-based formats is still in its early days. Using the patented anti-GPC-1 Miltuximab® as a case study, we have made an attempt to illustrate a pathway for preclinical to clinical translation, which could be useful for newer GPC-1 targeting immunotherapy agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
东方元语
wwww
cdercder
OK
Nole
Kao
颂歌998
aajhajkahna
学术文献互助
xing_xing
Maestro_S
馆长
qfyyyyyyy
dde
zy
arniu2008
11111111
科研小能手
初景
吃饱喝足
皖公网安备34019202002308
